Axsome Therapeutics, Inc. (AXSM) – Buy Price: $96 or better

Buy Price: $96 or better
Sell Price: TradersPro Sell Signal

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the phase III clinical trial for the treatment resistant depression and depressive disorders; and phase II/III clinical trials in agitation associated with Alzheimer’s disease, as well as completed phase II clinical trial for the treatment of smoking cessation.

 
Trending Ideas

Featured Stocks On The Move

Featured Stocks On The Move